BASTIDE LE CONFORT MEDICAL (BLC.PA) Stock Fundamental Analysis
EPA:BLC - Euronext Paris - Matif - FR0000035370 - Common Stock - Currency: EUR
Taking everything into account, BLC scores 4 out of 10 in our fundamental rating. BLC was compared to 25 industry peers in the Health Care Providers & Services industry. BLC has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLC is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
BLC had positive earnings in the past year.
BLC had a positive operating cash flow in the past year.
Of the past 5 years BLC 4 years were profitable.
Each year in the past 5 years BLC had a positive operating cash flow.
1.2 Ratios
BLC has a Return On Assets of 0.25%. This is in the lower half of the industry: BLC underperforms 68.00% of its industry peers.
The Return On Equity of BLC (2.25%) is worse than 60.00% of its industry peers.
The Return On Invested Capital of BLC (5.65%) is better than 64.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BLC is in line with the industry average of 5.77%.
The last Return On Invested Capital (5.65%) for BLC is above the 3 year average (5.34%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 2.25% | ||
| ROIC | 5.65% |
ROA(3y)1.29%
ROA(5y)1.7%
ROE(3y)9.6%
ROE(5y)12.13%
ROIC(3y)5.34%
ROIC(5y)5.17%
1.3 Margins
With a Profit Margin value of 0.32%, BLC is not doing good in the industry: 64.00% of the companies in the same industry are doing better.
The Operating Margin of BLC (7.67%) is comparable to the rest of the industry.
BLC's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 67.54%, BLC is doing good in the industry, outperforming 68.00% of the companies in the same industry.
In the last couple of years the Gross Margin of BLC has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.67% | ||
| PM (TTM) | 0.32% | ||
| GM | 67.54% |
OM growth 3Y3.59%
OM growth 5Y6.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.18%
GM growth 5Y6.9%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BLC is still creating some value.
The number of shares outstanding for BLC has been reduced compared to 1 year ago.
Compared to 5 years ago, BLC has more shares outstanding
The debt/assets ratio for BLC has been reduced compared to a year ago.
2.2 Solvency
BLC has an Altman-Z score of 1.43. This is a bad value and indicates that BLC is not financially healthy and even has some risk of bankruptcy.
BLC has a Altman-Z score of 1.43. This is comparable to the rest of the industry: BLC outperforms 48.00% of its industry peers.
The Debt to FCF ratio of BLC is 9.33, which is on the high side as it means it would take BLC, 9.33 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 9.33, BLC perfoms like the industry average, outperforming 48.00% of the companies in the same industry.
BLC has a Debt/Equity ratio of 5.20. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BLC (5.20) is worse than 84.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.2 | ||
| Debt/FCF | 9.33 | ||
| Altman-Z | 1.43 |
ROIC/WACC1.16
WACC4.86%
2.3 Liquidity
BLC has a Current Ratio of 1.19. This is a normal value and indicates that BLC is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.19, BLC is doing good in the industry, outperforming 64.00% of the companies in the same industry.
A Quick Ratio of 0.96 indicates that BLC may have some problems paying its short term obligations.
BLC's Quick ratio of 0.96 is in line compared to the rest of the industry. BLC outperforms 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.19 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
The earnings per share for BLC have decreased strongly by -71.43% in the last year.
The Revenue has been growing slightly by 3.24% in the past year.
The Revenue has been growing by 9.55% on average over the past years. This is quite good.
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.77%
Revenue 1Y (TTM)3.24%
Revenue growth 3Y6.06%
Revenue growth 5Y9.55%
Sales Q2Q%3.96%
3.2 Future
Based on estimates for the next years, BLC will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.74% on average per year.
BLC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.06% yearly.
EPS Next Y9.69%
EPS Next 2Y14.54%
EPS Next 3Y15.74%
EPS Next 5YN/A
Revenue Next Year7.14%
Revenue Next 2Y6.99%
Revenue Next 3Y6.96%
Revenue Next 5Y5.06%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 143.18 indicates a quite expensive valuation of BLC.
Based on the Price/Earnings ratio, BLC is valued a bit more expensive than 68.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.45. BLC is valued rather expensively when compared to this.
BLC is valuated reasonably with a Price/Forward Earnings ratio of 9.21.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLC indicates a rather cheap valuation: BLC is cheaper than 92.00% of the companies listed in the same industry.
BLC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.90.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 143.18 | ||
| Fwd PE | 9.21 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLC indicates a rather cheap valuation: BLC is cheaper than 84.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BLC is valued a bit cheaper than the industry average as 76.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.14 | ||
| EV/EBITDA | 6.11 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BLC does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as BLC's earnings are expected to grow with 15.74% in the coming years.
PEG (NY)14.78
PEG (5Y)N/A
EPS Next 2Y14.54%
EPS Next 3Y15.74%
5. Dividend
5.1 Amount
No dividends for BLC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:BLC (7/3/2025, 7:00:00 PM)
31.5
+0.45 (+1.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners9.28%
Inst Owner ChangeN/A
Ins Owners1.58%
Ins Owner ChangeN/A
Market Cap231.84M
Analysts83.33
Price Target33.66 (6.86%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.22
Dividend Growth(5Y)-3.5%
DP42.86%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)15.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)25.78%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 143.18 | ||
| Fwd PE | 9.21 | ||
| P/S | 0.43 | ||
| P/FCF | 5.14 | ||
| P/OCF | 2.07 | ||
| P/B | 3.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.11 |
EPS(TTM)0.22
EY0.7%
EPS(NY)3.42
Fwd EY10.85%
FCF(TTM)6.13
FCFY19.45%
OCF(TTM)15.24
OCFY48.37%
SpS73.4
BVpS10.34
TBVpS-19.17
PEG (NY)14.78
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 2.25% | ||
| ROCE | 8.61% | ||
| ROIC | 5.65% | ||
| ROICexc | 5.65% | ||
| ROICexgc | 10.3% | ||
| OM | 7.67% | ||
| PM (TTM) | 0.32% | ||
| GM | 67.54% | ||
| FCFM | 8.35% |
ROA(3y)1.29%
ROA(5y)1.7%
ROE(3y)9.6%
ROE(5y)12.13%
ROIC(3y)5.34%
ROIC(5y)5.17%
ROICexc(3y)5.7%
ROICexc(5y)5.58%
ROICexgc(3y)12.68%
ROICexgc(5y)11.8%
ROCE(3y)8.16%
ROCE(5y)7.93%
ROICexcg growth 3Y11.16%
ROICexcg growth 5Y1.85%
ROICexc growth 3Y8.09%
ROICexc growth 5Y5.81%
OM growth 3Y3.59%
OM growth 5Y6.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.18%
GM growth 5Y6.9%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.2 | ||
| Debt/FCF | 9.33 | ||
| Debt/EBITDA | 3.72 | ||
| Cap/Depr | 103.59% | ||
| Cap/Sales | 12.41% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 105.61% | ||
| Profit Quality | 2640.05% | ||
| Current Ratio | 1.19 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 1.43 |
F-Score6
WACC4.86%
ROIC/WACC1.16
Cap/Depr(3y)89.47%
Cap/Depr(5y)88.81%
Cap/Sales(3y)10.8%
Cap/Sales(5y)10.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.77%
EPS Next Y9.69%
EPS Next 2Y14.54%
EPS Next 3Y15.74%
EPS Next 5YN/A
Revenue 1Y (TTM)3.24%
Revenue growth 3Y6.06%
Revenue growth 5Y9.55%
Sales Q2Q%3.96%
Revenue Next Year7.14%
Revenue Next 2Y6.99%
Revenue Next 3Y6.96%
Revenue Next 5Y5.06%
EBIT growth 1Y3.82%
EBIT growth 3Y9.86%
EBIT growth 5Y16.32%
EBIT Next Year166.67%
EBIT Next 3Y44.23%
EBIT Next 5YN/A
FCF growth 1Y197.72%
FCF growth 3Y10.22%
FCF growth 5Y6.95%
OCF growth 1Y63.86%
OCF growth 3Y7.62%
OCF growth 5Y8.72%